Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFBK
651
DELISTED
Northfield Bancorp
NFBK
| $27.6M | 0.02% |
2,394,887
-58,450
| -2% | -$635K |
|
652
First American
FAF
$7.56B
| $27.5M | 0.02% |
573,166
+336,323
| +142% | +$15.9M |
|
|
WBK
653
DELISTED
Westpac Banking Corporation
WBK
| $27.5M | 0.02% |
2,197,660
-552,600
| -20% | -$6.06M |
|
|
QADA
654
DELISTED
QAD Inc.
QADA
| $27.4M | 0.02% |
663,977
+43,200
| +7% | +$1.82M |
|
655
Federal Realty Investment Trust
FRT
$10.3B
| $27.3M | 0.02% |
320,600
+70,198
| +28% | +$5.67M |
|
656
Cohu
COHU
$2.76B
| $27.3M | 0.02% |
1,572,517
-167,200
| -10% | -$2.58M |
|
|
EBSB
657
DELISTED
Meridian Bancorp, Inc.
EBSB
| $27.2M | 0.02% |
2,343,859
-141,000
| -6% | -$1.57M |
|
|
SPNS
658
DELISTED
Sapiens International
SPNS
| $27.2M | 0.02% |
971,503
+47,100
| +5% | +$1.15M |
|
659
Xerox
XRX
$412M
| $27.1M | 0.02% |
1,772,785
+468,902
| +36% | +$8.09M |
|
|
CERN
660
DELISTED
Cerner Corp
CERN
| $27.1M | 0.02% |
395,404
-46,000
| -10% | -$3.16M |
|
661
CRISPR Therapeutics
CRSP
$5.22B
| $27.1M | 0.02% |
368,658
-140,517
| -28% | -$8.22M |
|
662
Halozyme
HALO
$11.4B
| $27M | 0.02% |
1,008,200
+684,800
| +212% | +$15.4M |
|
663
Zimmer Biomet
ZBH
$19B
| $27M | 0.02% |
233,192
-291,902
| -56% | -$33.6M |
|
664
Bruker
BRKR
$8.83B
| $27M | 0.02% |
663,710
+213,400
| +47% | +$8.4M |
|
|
CIO
665
DELISTED
City Office REIT
CIO
| $26.8M | 0.02% |
2,660,903
-757,894
| -22% | -$7.01M |
|
666
Bank of Hawaii
BOH
$3.15B
| $26.8M | 0.02% |
435,600
-190,700
| -30% | -$11.8M |
|
|
BMCH
667
DELISTED
BMC Stock Holdings, Inc
BMCH
| $26.7M | 0.02% |
1,060,849
-294,800
| -22% | -$6.52M |
|
668
Zymeworks
ZYME
$1.83B
| $26.7M | 0.02% |
739,134
-60,613
| -8% | -$2.23M |
|
669
NOV
NOV
$7.36B
| $26.6M | 0.02% |
2,172,610
+788,300
| +57% | +$9.69M |
|
670
Stryker
SYK
$131B
| $26.5M | 0.02% |
147,300
+115,900
| +369% | +$21.4M |
|
|
AMRN
671
Amarin Corp
AMRN
$299M
| $26.4M | 0.02% |
190,663
+72,463
| +61% | +$9.97M |
|
672
Watts Water Technologies
WTS
$12.8B
| $26.3M | 0.02% |
324,790
-94,100
| -22% | -$7.58M |
|
673
Safety Insurance
SAFT
$1.52B
| $26.3M | 0.02% |
344,900
+5,300
| +2% | +$415K |
|
|
LSI
674
DELISTED
Life Storage, Inc.
LSI
| $26.2M | 0.02% |
414,600
-444,750
| -52% | -$27.6M |
|
675
Telefônica Brasil
VIV
$18.1B
| $26.2M | 0.02% |
2,958,849
+950,796
| +47% | +$8.62M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.